THE WHAT? Symrise has successfully completed its first Environment, Social, Governance (ESG)-linked promissory loan notes transaction, secured at €750 million.
THE DETAILS A press release stated, “The ESG-linked promissory loan notes represent the Group’s second sustainable financing instrument. By directly linking the interest rate to the eco-efficiency of greenhouse gas emissions, Symrise combines economic progress and growth with sustainable and responsible actions.”
The transaction will be executed in five tranches with a maturity of four to ten years.
Three tranches feature a fixed coupon, while two are subject to variable interest rates. The interest rate or margin depends on the eco-efficiency of the Symrise Group’s greenhouse gas emissions.
THE WHY? According to Symrise, the proceeds will be used for general corporate purposes and to finance strategic growth investments.
Olaf Klinger, Chief Finance Officer, Symrise, said, “At Symrise, we firmly believe that economic and ecological as well as socially responsible actions go hand in hand. Following our sustainable revolving credit line of fiscal year 2021, we therefore decided to once again incorporate sustainability aspects into our latest refinancing.
“The loan’s strong response in the current market environment reflects our stable business model, our sustainability expertise and the trust in our proven strategy. We are pleased that we have attracted such a broad investor portfolio at very favorable terms with the first ESG-linked promissory loan notes.”
Aesthetic injectable companies refer to businesses or companies that specialize in manufacturing, distributing, or providing aesthetic injectable products and services. These companies focus on developing and supplying injectable substances used for cosmetic purposes, typically administered by qualified medical professionals. Aesthetic injectable companies play a crucial role in the field of aesthetic medicine and cosmetic dermatology by offering a variety of injectable products designed to enhance facial features, reduce wrinkles, and improve overall skin appearance.
Key aspects of aesthetic injectable companies include:
-
Product Development: These companies research, develop, and manufacture aesthetic injectables such as dermal fillers, botulinum toxins (e.g., Botox), collagen stimulators, and other specialized formulations. They often innovate new products to meet evolving market demands and technological advancements.
-
Distribution and Sales: Aesthetic injectable companies distribute their products through authorized channels, including healthcare providers, medical spas, and aesthetic clinics. They may also sell directly to licensed professionals who administer these treatments.
-
Regulatory Compliance: Due to the medical nature of their products, aesthetic injectable companies adhere to strict regulatory guidelines and obtain necessary approvals from health authorities (e.g., FDA in the United States) to ensure safety, efficacy, and quality standards.
-
Training and Support: Many companies provide training and educational support to healthcare professionals on the proper use, administration techniques, and safety protocols associated with their injectable products. This ensures that practitioners can deliver treatments effectively and safely.
-
Customer Support: Aesthetic injectable companies offer customer support services to healthcare providers and consumers, addressing inquiries, providing product information, and assisting with product usage and troubleshooting.
